Mary Kay Koenig from UTHealth Houston with a discussion focused on addressing the high unmet need in Ataxia-Telangiectasia (A-T). Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief ...

Mary Kay Koenig from UTHealth Houston with a discussion focused on addressing the high unmet need in Ataxia-Telangiectasia (A-T). Quince also disclosed that the company has enrolled 46 ...

Phase 3 NEAT clinical trial nearing 50% enrollment; company reiterates expectation of enrollment completion in second quarter of 2025 and topline results in fourth quarter of 2025 Dirk Thye, M.D ...

Pivotal Phase 3 NEAT Clinical Trial Quince will host an investor webinar today focused on addressing the high unmet need in the company’s lead rare pediatric neurodegenerative disease indication, ...

Man, she feels like a tongue! Shania Twain stars in a new commercial for Coffee mate, set to air during the 2025 Super Bowl, in which she plays a singing version of the oral organ to promote the ...

1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. *Corresponding Author: Jann N. Sarkaria, Department of Radiation Oncology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905.

After the match, Kevin Pietersen asked Gautam Gambhir about Harshit Rana being used as a like-for-like replacement for Shivam Dube in the fourth T20I. Indian Cricket Team head coach Gautam Gambhir ...

“We have the first device to treat macular telangiectasia type 2, which has been through the clinical trial program, and the long-term results up to 9 years find that it is still relatively well ...